One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Urinary Catheters Market

[ 英語タイトル ] Urinary Catheters Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0082322
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Amsino International Inc.
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Coloplast AS
- ConvaTec Group PLC
- Cook Medical
- Cure Medical LLC
- Hollister Incorporated
- Medtronic
- Teleflex Incorporated

[Report Description]

The major factors driving the growth of the urinary catheters market include the rising prevalence of urinary incontinence, growing geriatric population, and technological advancement in the material used for catheters.

Urinary incontinence (UI) is one of the underdiagnosed and underreported problems that increase with age and affect a high percentage of the elderly population (nearly 50-85% in the long-term care facilities). According to the National Association for Incontinence (NAFC), nearly 200 million people are affected by UI. As per the, UI is twice as common in women as in men, where stress UI is most common among women who are pregnant, giving birth, or going through menopause. These are the major reasons for the rise in the incidence of UI. UI has a varied presence in major geographies across the world. It is common in most parts of Europe and North America, while it is uncommon in most of the developing Asian countries. According to a recent article published in 2017 in the British Medical Journal Open (BMJ Open), a study on the prevalence of urinary catheters in England during the period of 2012 to 2016 indicated that urinary catheters are highly ubiquitous with every 1 in 5 patients in hospital and 1 in 14 in community care getting catheterized. Catheterization is one of the primary solutions for many individuals affected by urinary dysfunction caused by neurological diseases. Many companies are developing user-friendly urinary self-catheterization, which can be performed by individuals themselves or by the assistance of a nurse or a relative. This shows that the awareness among public also plays a major role in the increasing demand for urinary catheters, especially in developed markets, such as the United States, the United Kingdom, Germany, and France, among others. The rising prevalence of urinary incontinence is expected to drive growth in the urinary catheter market during the forecast period.

Key Market Trends

Application in Spinal Surgery is Expected to Rise in Future

Postoperative urinary retention (POUR) refers to patients' inability to void urine in spite of full bladder after the surgical intervention in the postoperative period. The inadequate treatment of POUR can result in the overdistention injury of the bladder, bladder detrusor muscle hypertrophy, and overactive voiding symptoms. Among the conservative treatment options for POUR, Foley catheterization (FC) and intermittent catheterization (IC) is generally considered safe for short-term use in neurologic patients.

Spinal surgeries are very common in the geriatric population. Moreover, the percentage of the population aged 60 years or above is expected to increase, globally, from 12.7% in 2017 to nearly 21.3% by 2050, as per United Nations 2017 report. Hence, the number of spinal surgeries are also expected to increase. This is expected to boost the demand for the market.

North America Accounted for the Largest Share in the Market

North America occupied a major share in the urinary catheters market, and the region is expected to show a similar trend over the forecast period, without significant fluctuations. The United States holds one of the largest shares in the market, due to better healthcare infrastructure, effective government policies, a huge base of multinational companies, and high awareness among people regarding urinary dysfunction. A large number of catheter-based clinical trial studies involve major hospital chains and research centers, in collaboration with multinational companies, such as the University of Rochester Medical Center, Massachusetts General Hospital Boston, and others. According to the Centers for Medicare and Medicaid Services, the national health expenditure had grown by 4.6% in 2017, to nearly 3.5 trillion, currently. Improved regulatory medical device guidelines and reimbursement policies make the United States a country with a higher investment opportunity and it is expected to witness high growth during the forecast period.

Competitive Landscape

The market studied is moderately consolidated with the presence of few major players and small players. The market players are focusing on R&D to develop technologically advanced products in the market. The barriers for the new entrants are high in this industry, and hence, few major market players hold the maximum market share.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Urinary Incontinence
4.2.2 Growing Geriatric Population
4.2.3 Technological Advancement in the Material Used for Catheters
4.3 Market Restraints
4.3.1 Risk of Catheter-associated Urinary Tract Infection (CAUTI)
4.3.2 Alternative Treatment Options for Urinary Incontinence
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product Type
5.1.1 Indwelling (Foley) Catheters
5.1.2 Intermittent Catheters
5.1.3 External Catheters
5.2 By Application
5.2.1 Benign Prostate Hyperplasia (BPH)
5.2.2 Urinary Incontinence
5.2.3 Spinal Cord Injury
5.2.4 Other Applications
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Amsino International Inc.
6.1.2 B. Braun Melsungen AG
6.1.3 Boston Scientific Corporation
6.1.4 Coloplast AS
6.1.5 ConvaTec Group PLC
6.1.6 Cook Medical
6.1.7 Cure Medical LLC
6.1.8 Hollister Incorporated
6.1.9 Medtronic
6.1.10 Teleflex Incorporated




Recommended reports